Effects of estrogen on osteoprogenitor cells and cytokines/bone-regulatory factors in postmenopausal women
Authors:
- Matthew M. RoforthMRMatthew M. Roforth
- Kelley HoeyKHKelley Hoey
- Louise K. McCreadyLMLouise K. McCready
- James M. PetersonJPJames M. Peterson
- David G. MonroeDMDavid G. Monroe
- Merry Jo OurslerMOMerry Jo Oursler
- Sundeep KhoslaSKSundeep Khosla
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Regulation of circulating sclerostin levels by sex steroids in women and in menJournal of Bone and Mineral Research, 2010
- The unitary model for estrogen deficiency and the pathogenesis of osteoporosis: Is a revision needed?Journal of Bone and Mineral Research, 2010
- Relation of age, gender, and bone mass to circulating sclerostin levels in women and menJournal of Bone and Mineral Research, 2010
- Update on Estrogens and the SkeletonThe Journal of Clinical Endocrinology & Metabolism, 2010
- Serum Sclerostin Levels Negatively Correlate with Parathyroid Hormone Levels and Free Estrogen Index in Postmenopausal WomenThe Journal of Clinical Endocrinology & Metabolism, 2010
- The emerging role of serotonin (5-hydroxytryptamine) in the skeleton and its mediation of the skeletal effects of low-density lipoprotein receptor-related protein 5 (LRP5)Bone, 2010
- Effects of estrogen therapy on bone marrow adipocytes in postmenopausal osteoporotic womenOsteoporosis International, 2008
- Playing with bone and fatJournal of Cellular Biochemistry, 2006
- Comprehensive Algorithm for Quantitative Real-Time Polymerase Chain ReactionJournal of Computational Biology, 2005
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005